This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 1976.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976
Title: Klaus Engel: Innovator in Estrogenic Treatments
Introduction
Klaus Engel is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address estrogenic deficiency conditions.
Latest Patents
Engel holds a patent for 3,17,18-Trihydroxy-1,3,5(10)-estratrienes. This compound, represented by the formula ##SPC1##, features R as either hydrogen or a substituted or unsubstituted saturated or unsaturated hydrocarbon, along with esters and ethers. The patent highlights the compound's strong vaginotropic activity and only weak uterotropic activity, making it useful in treating conditions where uterine effects are not desired.
Career Highlights
Klaus Engel has worked with Schering Aktiengesellschaft, a prominent pharmaceutical company. His work has focused on innovative treatments that improve women's health, particularly in areas where traditional estrogen therapies may not be suitable.
Collaborations
Engel has collaborated with notable colleagues, including Klaus Prezewowsky and Henry Laurent. Their combined expertise has contributed to advancements in the pharmaceutical industry.
Conclusion
Klaus Engel's work in developing estrogenic treatments showcases his commitment to improving health outcomes for women. His innovative patent reflects the potential for targeted therapies in addressing specific medical needs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile